Lidoflazine
![]() | |
Clinical data | |
---|---|
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C30H35F2N3O |
Molar mass | 491.615 |
WikiDoc Resources for Lidoflazine |
Articles |
---|
Most recent articles on Lidoflazine Most cited articles on Lidoflazine |
Media |
Powerpoint slides on Lidoflazine |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Lidoflazine at Clinical Trials.gov Clinical Trials on Lidoflazine at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Lidoflazine
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Lidoflazine Discussion groups on Lidoflazine Patient Handouts on Lidoflazine Directions to Hospitals Treating Lidoflazine Risk calculators and risk factors for Lidoflazine
|
Healthcare Provider Resources |
Causes & Risk Factors for Lidoflazine |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Lidoflazine is a piperazine calcium channel blocker. It is a coronary vasodilator with some antiarrhythmic action.[1] Lidoflazine was discovered at Janssen Pharmaceutica in 1964.
Physical properties
Solubility at room temperature
Extracted from [2]
Solvent | 0.01
N |
0.1
N | ||
% | pH | % | pH | |
Hydrochloric Acid | 0.4 | 3.0 | 0.7 | 1.9 |
Tartaric Acid | 0.3 | 3.1 | 1.0 | 2.5 |
Citric Acid | 0.3 | 3.1 | 0.5 | 2.5 |
Lactic Acid | 0.2 | 3.4 | 0.7 | 2.9 |
Acetic Acid | 0.1 | 3.5 | 0.4 | 3.8 |
References
- ↑ Schaper, W.K.A.; Xhonneux, R.; Jageneau, A.H.M.; Janssen, P.A.J. (1966). "The cardiovascular pharmacology of lidoflazine, a long-acting coronary vasodilator". Journal of Pharmacology and Experimental Therapeutics. 152 (2): 265–274. PMID 5944369. Retrieved 2009-06-20.
- ↑ http://jpet.aspetjournals.org/cgi/content/abstract/152/2/265
- Schaper WK, Xhonneux R, Jageneau AH., Stimulation of the coronary collateral circulation by lidoflazine (R 7904), Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1965 Nov 4;252(1):1-8.
- Schaper WK, Xhoneux R, Jageneau AH, Janssen PA., The cardiovascular pharmacology of lidoflazine, a long-acting coronary vasodilator, J Pharmacol Exp Ther. 1966 May;152(2):265-74.
- Pages with script errors
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Chemical articles with unknown parameter in Infobox drug
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Calcium channel blockers
- Cardiovascular Drugs
- Drug